Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Aristo Bio-Tech And Lifescience Limited (NSE: ARISTO), ISIN INE082101010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ARISTO last traded at ₹112.00 (+5.81%), with a 52-week range of ₹74.30 to ₹137.80 (as of 23 Sep 2026).
Shareholding as of Mar 2026: promoters 73.42%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 75/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.